N. Mar

发表

CCR 20 th Anniversary Commentary : Bevacizumab in the Treatment of Glioblastoma — The Progress and the

A. Desjardins, J. Vredenburgh, N. Mar, 2015 .

Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response.

M. Saif, S. Khaled, N. Mar, 2006, Anti-cancer drugs.

Challenges in managing a patient with multiple primary malignancies

R. Graham, N. Mar, D. Askin, 2012 .

Rubinstein–Taybi syndrome – a window into follicular lymphoma biology

Joseph A. DiGiuseppe, N. Mar, M. Dailey, 2016, Leukemia & lymphoma.

Renal Cell Carcinoma-Lessons in Diversity, Breakthroughs, and Challenges.

Dalia Kaakour, N. Mar, A. Rezazadeh Kalebasty, 2021, JCO oncology practice.

Use of immunotherapy in clinical management of genitourinary cancers - a review.

E. Uchio, N. Mar, A. R. Kalebasty, 2022, Cancer treatment and research communications.

Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss

N. Mar, K. Hook, Rebecca L. Kosowicz, 2014, Journal of Thrombosis and Thrombolysis.

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma

N. Mar, A. Rezazadeh Kalebasty, D. J. Benjamin, 2022, Clinical Medicine Insights. Oncology.

Late recurrence of localized pure seminoma in prostate gland: A case report

Abinav Baweja, N. Mar, A. Rezazadeh Kalebasty, 2022, World journal of clinical oncology.

Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult Questions.

N. Mar, F. Dayyani, 2019, Journal of oncology practice.

Lung abscess, esophageal dilation, and bulimia--six degrees of separation from adjustable gastric banding.

Robert E. Graham, N. Mar, 2012, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Blue toes and a new pair of shoes—Challenges in diagnosis and treatment of acute myelogenous leukemia

J. Vredenburgh, N. Mar, M. Gorgan, 2013, American journal of hematology.

L. Shields, N. Mar, A. Rezazadeh Kalebasty, 2021, Case Reports in Oncology.

Potential Costs of Inappropriate Use of Proton Pump Inhibitors

G. Panagopoulos, N. Mar, R. Graham, 2014, The American journal of the medical sciences.

Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab

Abinav Baweja, N. Mar, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

A. Tafreshi, J. Bono, S. Oudard, 2020 .

Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas.

E. Uchio, N. Mar, A. R. Kalebasty, 2020, JCO oncology practice.

Aberrant vascular network within the heart as a consequence of metastatic renal cell carcinoma

R. Houshyar, N. Mar, Chris W. Pan, 2018, Journal of Clinical Urology.

Metastatic Clinically-Aggressive Non-Invasive Low-Grade Urothelial Carcinoma Arising Post Autologous Transplant - Case Report and Review of the Literature

N. Mar, A. R. Kalebasty, Roozbeh Housyar, 2021 .

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients (pts) with muscle invasive bladder cancer (MIBC) who are cisplatin-ineligible.

S. Srinivas, J. Rosenberg, D. Petrylak, 2022, Journal of Clinical Oncology.

Targeting HER2 in the treatment of non-small cell lung cancer.

J. Vredenburgh, J. Wasser, N. Mar, 2015, Lung cancer.

Use of Neoadjuvant Sunitinib in Renal Cell Carcinoma of a Transplanted Kidney.

R. Houshyar, N. Mar, Mark Jordan, 2018, Journal of oncology practice.

Multiple lymphomatous polyposis as a sole presentation of mantle cell lymphoma.

U. Gergis, S. Khaled, V. Gotlieb, 2006, Journal of clinical gastroenterology.

Development of carpal tunnel syndrome in association with checkpoint inhibitors

S. Ejadi, N. Mar, L. Eisenbud, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

CCR 20th Anniversary Commentary: Bevacizumab in the Treatment of Glioblastoma—The Progress and the Limitations

A. Desjardins, J. Vredenburgh, N. Mar, 2015, Clinical Cancer Research.

Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study

R. Houshyar, Dalia Kaakour, N. Mar, 2022, Biomedicines.

Cutaneous reactions with enfortumab vedotin: A case series and review of the literature

A. Dobry, N. Mar, Janellen Smith, 2021, JAAD case reports.

LBA73 Study EV-103 Cohort K: Antitumor activity of enfortumab vedotin (EV) monotherapy or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC)

M. Milowsky, P. O’Donnell, D. Petrylak, 2022, Annals of Oncology.

Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress).

S. Srinivas, J. Rosenberg, P. O’Donnell, 2022, Journal of Clinical Oncology.

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

B. Mellado, Y. Zakharia, M. Teo, 2023, Cancers.

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy

L. Shields, N. Mar, A. Rezazadeh Kalebasty, 2021, World journal of clinical oncology.

Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.

N. Mar, Antonio Mendoza Ladd, 2011, Journal of thrombosis and thrombolysis.

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

M. Milowsky, S. Srinivas, J. Rosenberg, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Drug extravasation with Enfortumab vedotin

N. Mar, A. R. Kalebasty, C. Grant, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Targeting HER2 in the treatment of non-small cell lung cancer.

J. Vredenburgh, J. Wasser, N. Mar, 2015, Lung cancer.

An image analysis on MR imaging of the brain for hepatic encephalopathy.

J. McConnell, W. Chu, N. Mar, 1991, Biomedical sciences instrumentation.